Neuralink's "Blindsight" vision restoration implant receives FDA's "breakthrough device" designation.

Neuralink, Elon Musk's neurotechnology startup, has received "breakthrough device" designation from the U.S. FDA for its vision restoration implant, "Blindsight." This designation expedites the development of devices treating life-threatening conditions. The implant aims to assist those who are blind, bypassing damaged optic pathways. Neuralink is also testing technology that allows paralyzed patients to control digital devices with their thoughts, with trials expected to last several years.

September 17, 2024
68 Articles